TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - NOVO-NORDISK B Share Price

Certificat

DE000CL7HDG3

Market Closed - Boerse Frankfurt Warrants 20:40:15 07/06/2024 BST
21.32 EUR +2.30% Intraday chart for TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - NOVO-NORDISK B
Current month+8.49%
1 month+15.54%
Date Price Change
07/06/24 21.34 +2.40%
06/06/24 20.84 +0.97%
05/06/24 20.64 +1.72%
04/06/24 20.29 +3.36%
03/06/24 19.63 -0.20%

Real-time Boerse Frankfurt Warrants

Last update June 07, 2024 at 08:40 pm

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellCALL
Underlying NOVO NORDISK A/S
IssuerLogo Issuer Société Générale Société Générale
WKN CL7HDG
ISINDE000CL7HDG3
Date issued 07/04/2020
Strike 195 kr
Maturity Unlimited
Parity 5 : 1
Emission price 1
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 21.39
Lowest since issue 0.72

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
984 DKK
Average target price
920.8 DKK
Spread / Average Target
-6.43%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW